These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 37051571)

  • 21. The Value of Platelet-to-Lymphocyte Ratio as a Prognostic Marker in Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
    Liu D; Czigany Z; Heij LR; Bouwense SAW; van Dam R; Lang SA; Ulmer TF; Neumann UP; Bednarsch J
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis.
    Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
    Onco Targets Ther; 2016; 9():869-76. PubMed ID: 26955285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
    Peng H; Luo X
    Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic evaluation of platelet to lymphocyte ratio in patients with colorectal cancer.
    Lu C; Gao P; Yang Y; Chen X; Wang L; Yu D; Song Y; Xu Q; Wang Z
    Oncotarget; 2017 Oct; 8(49):86287-86295. PubMed ID: 29156795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the prognosis of resected early-stage patients with non-small cell lung cancer: A meta-analysis.
    Cao W; Yu H; Zhu S; Lei X; Li T; Ren F; Zhou N; Tang Q; Zu L; Xu S
    Cancer Med; 2023 Mar; 12(6):7065-7076. PubMed ID: 36480232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
    Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
    Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis.
    Liu XB; Gao ZY; Zhang QH; Pandey S; Gao B; Yang F; Tong Q; Li SB
    Front Oncol; 2020; 10():178. PubMed ID: 32154173
    [No Abstract]   [Full Text] [Related]  

  • 28. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
    Zhang N; Jiang J; Tang S; Sun G
    Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
    Xu H; He A; Liu A; Tong W; Cao D
    Int Immunopharmacol; 2019 Dec; 77():105957. PubMed ID: 31677498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis.
    Qi X; Chen J; Wei S; Ni J; Song L; Jin C; Yang L; Zhang X
    BMJ Open; 2023 Nov; 13(11):e074874. PubMed ID: 37996220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
    Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
    BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
    Li W; Tao L; Lu M; Xiu D
    Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.
    Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Cunningham D; Mudan S
    Med Oncol; 2014 Oct; 31(10):239. PubMed ID: 25218270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
    Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
    Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Cholangiocarcinoma: A Meta-Analysis.
    Hu G; Liu Q; Ma JY; Liu CY
    Biomed Res Int; 2018; 2018():7375169. PubMed ID: 30539019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of the Platelet-to-Lymphocyte Ratio in Patients With Melanoma: A Meta-Analysis.
    Zhang F; Gong W
    Front Oncol; 2020; 10():1116. PubMed ID: 32850320
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in laryngeal cancer: What should we expect from a meta-analysis?
    Hu X; Tian T; Sun Q; Jiang W
    Front Oncol; 2022; 12():945820. PubMed ID: 36033468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.
    Wang X; Su S; Guo Y
    Oncotarget; 2017 Oct; 8(48):84506-84514. PubMed ID: 29137443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer.
    Wang J; Liu Y; Zhang N; Li X; Xin P; Bi J; Kong C
    Oncotarget; 2017 Sep; 8(41):70874-70882. PubMed ID: 29050328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.